IL-1β antibodies, for instance, have shown promise in reducingmyocardial infarction and angina in patients with atherosclerosis [9, 101].Additionally, IL-1β receptor antagonists effectively prevent myocardialdysfunction and arrhythmias in Kawasaki disease, underscoring the potential ofIL-1β-targeted treatments for arrhythmias [102]. The gene discussed is IL1B; the disease is cardiac arrhythmia.